dc.contributor.author |
Stoikov I. |
|
dc.contributor.author |
Khrustalev A. |
|
dc.contributor.author |
Ibragimova D. |
|
dc.contributor.author |
Stoikova E. |
|
dc.contributor.author |
Evtyugin G. |
|
dc.contributor.author |
Antipin I. |
|
dc.contributor.author |
Konovalov A. |
|
dc.date.accessioned |
2018-09-17T21:26:10Z |
|
dc.date.available |
2018-09-17T21:26:10Z |
|
dc.date.issued |
2005 |
|
dc.identifier.issn |
1070-3632 |
|
dc.identifier.uri |
https://dspace.kpfu.ru/xmlui/handle/net/134990 |
|
dc.description.abstract |
New reversible butyrylcholine esterase inhibitors based on calix[4]arene derivatives were suggested. A series of new distally disubstituted calix[4]arenes were prepared in 60-80% yields. Some of these compounds showed properties of reversible choline esterase effectors, activating it at low concentrations and inhibiting at high concentrations. The macrocycles prepared were tested in extraction of d,l-tartaric, glycolic, d,l-mandelic, d,l-glutamic, malonic, oxalic, and succinic acids and of sodium acetate. Oxalic acid is efficiently transferred through a liquid impregnated membrane under the action of calix[4]arenes with nitrogen-containing substituents. ©2005 Pleiades Publishing, Inc. |
|
dc.relation.ispartofseries |
Russian Journal of General Chemistry |
|
dc.title |
Choline esterase inhibitors and synthetic oxalic acid receptors based on calix[4]arene derivatives |
|
dc.type |
Article |
|
dc.relation.ispartofseries-issue |
2 |
|
dc.relation.ispartofseries-volume |
75 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.relation.startpage |
278 |
|
dc.source.id |
SCOPUS10703632-2005-75-2-SID24644517525 |
|